<SEC-DOCUMENT>0000950170-25-017068.txt : 20250210
<SEC-HEADER>0000950170-25-017068.hdr.sgml : 20250210
<ACCEPTANCE-DATETIME>20250210161018
ACCESSION NUMBER:		0000950170-25-017068
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20250210
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250210
DATE AS OF CHANGE:		20250210

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ACHIEVE LIFE SCIENCES, INC.
		CENTRAL INDEX KEY:			0000949858
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				954343413
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	033-80623
		FILM NUMBER:		25605846

	BUSINESS ADDRESS:	
		STREET 1:		22722 29TH DR. SE
		STREET 2:		SUITE 100
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98021
		BUSINESS PHONE:		425-686-1500

	MAIL ADDRESS:	
		STREET 1:		22722 29TH DR. SE
		STREET 2:		SUITE 100
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98021

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ONCOGENEX PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20080821

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SONUS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19950825
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>achv-20250210.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-02-10T13:39:33.6644+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:achv="http://ir.achievelifesciences.com/20250210" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:utr="http://www.xbrl.org/2009/utr">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_62a9e576-8a48-4881-b996-0d85c925e306" name="dei:AmendmentFlag" contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric id="F_7f90f156-3ad3-4352-b8f4-80350751b49f" name="dei:EntityCentralIndexKey" contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd">0000949858</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="achv-20250210.xsd"/></ix:references><ix:resources><xbrli:context id="C_a3d0af1b-4e13-4822-9148-507ec4d52c9f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000949858</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:OtherAddressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-10</xbrli:startDate><xbrli:endDate>2025-02-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000949858</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-10</xbrli:startDate><xbrli:endDate>2025-02-10</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="border-top:2.25pt double;padding-top:1pt;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Washington, D.C. 20549</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid #000000;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d6d3906d-ddcd-4119-ac46-cb3ccdb112c5" contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8-K</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid #000000;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CURRENT REPORT</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Section 13 or 15(d)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of the Securities Exchange Act of 1934</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span style="font-size:11pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8ffa17e2-8832-4ad2-a8ce-32f94653a8ff" contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">February 10, 2025</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid #000000;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:24pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8e937ade-1da2-4a51-afe2-51e4e1d9e5fd" contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ACHIEVE LIFE SCIENCES, INC.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid #000000;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:29.76%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:35.4%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:32.84%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:48pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="margin-left:48pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_98cd1da7-3a16-4926-83e9-f7d933597da8" contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;text-indent:28.5pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="margin-left:28.5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_bdd60083-c35c-4064-a551-e2c99d82daea" contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">033-80623</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_0dd18008-62be-402c-97df-560911ba2539" contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">95-4343413</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:48pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="margin-left:48pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(State or Other Jurisdiction</span></p><p style="margin-left:48pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">of Incorporation)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;text-indent:28.5pt;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="margin-left:28.5pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Commission</span></p><p style="margin-left:28.5pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">File Number)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(IRS Employer</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Identification No.)</span></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="3" style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.71875in;text-align:center;"><span><ix:nonNumeric id="F_2bd0c80e-9bdc-4f30-9bb9-644aee26afc8" contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">22722 29th Drive SE</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_a7075460-fa16-43eb-bd28-6c0b00f2af7c" contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd" name="dei:EntityAddressAddressLine2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Suite 100</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;margin-right:1.71875in;text-align:center;"><span><ix:nonNumeric id="F_469957d2-a73f-4b6a-9961-36fe379d6343" contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Bothell</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_d67fe97b-c806-4d7d-a16a-df7e0e104b52" contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd" name="dei:EntityAddressStateOrProvince"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">WA</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.71875in;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:14.15pt;text-align:center;"><span><ix:nonNumeric id="F_40299683-fd51-40b6-bcbf-8f96a1875f5c" contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">98021</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.71875in;text-align:center;"><span><ix:nonNumeric id="F_b95ef069-f7ed-4f09-a321-bca531ee3c66" contextRef="C_a3d0af1b-4e13-4822-9148-507ec4d52c9f" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">1040 West Georgia</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_71bc7558-c268-48c1-90e5-d063bbd68f6f" contextRef="C_a3d0af1b-4e13-4822-9148-507ec4d52c9f" name="dei:EntityAddressAddressLine2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Suite 1030</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;margin-right:1.71875in;text-align:center;"><span><ix:nonNumeric id="F_35fc844c-e145-477a-9961-0165f3ba0cca" contextRef="C_a3d0af1b-4e13-4822-9148-507ec4d52c9f" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Vancouver</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_8c782576-69da-41f1-968f-bc3f74d1ca70" contextRef="C_a3d0af1b-4e13-4822-9148-507ec4d52c9f" name="dei:EntityAddressStateOrProvince"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">BC</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_cc363098-3980-4b30-b87b-cbdd774c229f" contextRef="C_a3d0af1b-4e13-4822-9148-507ec4d52c9f" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Canada</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_5c01132e-02e2-45bb-81de-db9ac4cbb842" contextRef="C_a3d0af1b-4e13-4822-9148-507ec4d52c9f" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">V6E 4H1</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.71875in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Registrant&#8217;s Telephone Number, Including Area Code: (</span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d048b0b7-35b0-4fa1-b156-58021a94ddd1" contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">604</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2bb12bd3-6884-4cd9-b7d9-e99750b6571d" contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">210-2217</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">N/A</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid #000000;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <table style="border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:3.04%;box-sizing:content-box;"/>
    <td style="width:96.96%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:12pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_a94867dd-f096-4925-866f-fe3f7be0db2a" contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <table style="border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:3.04%;box-sizing:content-box;"/>
    <td style="width:96.96%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:12pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_6658b33e-fa3b-4582-b72b-d014b3c6d224" contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <table style="border-spacing:0;table-layout:auto;width:86.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:2.46%;box-sizing:content-box;"/>
    <td style="width:97.54%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:12pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_e2517eda-df90-4de2-b707-9ca9ebe4f82f" contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <table style="border-spacing:0;table-layout:auto;width:86.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:2.48%;box-sizing:content-box;"/>
    <td style="width:97.52%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:12pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_3411db8f-c792-40ac-856c-24408f776486" contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <table style="border-spacing:0;table-layout:auto;width:96.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:37.56%;box-sizing:content-box;"/>
    <td style="width:27.82%;box-sizing:content-box;"/>
    <td style="width:34.62%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Title of each class</span></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Trading Symbol</span></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Name of exchange on which registered</span></p></td>
   </tr>
   <tr style="height:11pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_c397f2a0-4fce-4a3b-87a5-964fa9f0eba6" contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common Stock, par value $0.001 per share</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_7a5dfa64-37ec-4a19-8b75-003b9f9fe625" contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ACHV</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-kerning:none;min-width:fit-content;">The </span><span style="font-size:11pt;"><ix:nonNumeric id="F_abdbf461-5fd3-496f-ac04-97d2b9c715cc" contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Nasdaq</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-kerning:none;min-width:fit-content;">&#160;Stock Market LLC</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Emerging growth company  </span><span style="font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_e4d0f7a6-09f5-44eb-b1d2-0429952d054c" contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 8.01 Other Events.</span></p>
  <p style="font-size:10pt;margin-top:14pt;font-family:Times New Roman;margin-bottom:14pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 10, 2025, Achieve Life Sciences, Inc. (the &#8220;Company&#8221;) announced that the Data Safety Monitoring Committee (&#8220;DSMC&#8221;) recently completed its second independent review of the Company&#8217;s ongoing ORCA-OL trial, evaluating long-term exposure of the novel 3 mg cytisinicline treatment dosing regimen in individuals who smoke cigarettes or vape nicotine.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:14pt;font-family:Times New Roman;margin-bottom:14pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Following this second comprehensive review of available safety data, the DSMC stated that it did not identify any unexpected treatment-related adverse events and that the participants&#8217; adherence to their cytisinicline medication was excellent. Overall safety data remained consistent with previous findings. The DSMC concluded the study may continue as planned without any modifications.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9.01.  Financial Statements and Exhibits.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) 	Exhibits</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:12.06%;box-sizing:content-box;"/>
    <td style="width:1.54%;box-sizing:content-box;"/>
    <td style="width:86.4%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:11pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit No.</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #ffffff03;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid;text-align:left;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="height:11pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:11pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:30pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:20pt;text-indent:-10pt;padding-left:10pt;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99.1</span></p><p style="margin-left:20pt;text-indent:-10pt;padding-left:10pt;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="margin-left:20pt;text-indent:-10pt;padding-left:10pt;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;text-indent:72pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-72pt;padding-left:72pt;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><a href="achv-ex99_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Press release of Achieve Life Sciences, Inc. dated February 10, 2025</span></a></p><p style="text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;margin-right:6.667%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNATURES</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:45.18%;box-sizing:content-box;"/>
    <td style="width:54.82%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:11pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:right;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ACHIEVE LIFE SCIENCES, INC.</span></p></td>
   </tr>
   <tr style="height:11pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:right;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: February 10, 2025</span></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Mark Oki</span></p></td>
   </tr>
   <tr style="height:11pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;text-align:right;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Mark Oki</span></p><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Financial Officer (Principal Financial Officer)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>achv-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="z-index:-3;min-height:1in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">EXHIBIT 99.1</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:14pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:14pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:15pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:13.5pt;font-family:'Cambria',serif;font-style:italic;font-kerning:none;min-width:fit-content;">No Safety Concerns Identified by DSMC in the ORCA-OL Long-Term Exposure Trial</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:15pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:13.5pt;font-family:'Cambria',serif;font-style:italic;font-kerning:none;min-width:fit-content;">Achieve Reiterates Planned Cytisinicline NDA Submission in Q2 2025</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">SEATTLE and VANCOUVER, British Columbia, February 10, 2025 (GLOBE NEWSWIRE)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;"> &#x2013; Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that the Data Safety Monitoring Committee (DSMC) has recently completed its second independent review of the ongoing ORCA-OL trial, evaluating long-term exposure of the novel 3 mg cytisinicline treatment dosing regimen in individuals who smoke cigarettes or vape nicotine.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">Following this second comprehensive review of available safety data, the DSMC stated that it did not identify any unexpected treatment-related adverse events and that the participants&#x2019; adherence to their cytisinicline medication was excellent. Overall safety data remains consistent with previous findings. The DSMC concluded the study may continue as planned without any modifications.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">&#x201c;The positive outcome of the DSMC&#x2019;s second review continues to confirm the previous findings from our Phase 2 and Phase 3 trials regarding the overall safety of cytisinicline,&#x201d; said Cindy Jacobs, PhD, MD, President and Chief Medical Officer of Achieve. &#x201c;This reinforces our confidence in the cytisinicline safety profile from the ORCA-OL trial and the broader ORCA program, moving us closer to filing our cytisinicline New Drug Application or NDA.&#x201d;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">In October 2024, Achieve announced the completion of the ORCA-OL trial enrollment, with 479 participants enrolled across 29 clinical trial sites in the United States. All participating sites and individuals were previously involved in Achieve&#x2019;s ORCA &#x201c;Ongoing Research of Cytisinicline for Addiction&#x201d; program, which focused on smoking and e-cigarette cessation. In January 2025, Achieve announced that the ongoing ORCA-OL clinical trial had reached its goal of at least 300 participants completing six months of cumulative cytisinicline treatment, which was an important milestone for proceeding with the company&#x2019;s planned NDA filing.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:-3;min-height:1in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">Rick Stewart, Chief Executive Officer of Achieve, added, &#x201c;Achieve remains on track with our expected NDA submission next quarter for cytisinicline as a treatment of nicotine dependence for smoking cessation. We believe it will be the first new prescription treatment in nearly 20 years to provide physicians and smokers with an important new tool to stop smoking. Achieve remains focused on and committed to addressing the public health crisis of nicotine dependence.&#x201d;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">The ORCA-OL clinical trial is designed to satisfy the U.S. Food and Drug Administration&#x2019;s (FDA) long-term exposure safety data requirements for cytisinicline&#x2019;s potential approval. The FDA requested six-month safety exposure data from at least 300 participants who have been treated with cytisinicline to be included in the company&#x2019;s planned NDA, with one-year cumulative exposure safety data from a minimum of 100 participants treated with cytisinicline submitted during the NDA review period, prior to potential NDA approval.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">To date, Achieve has successfully completed two Phase 3 clinical trials of cytisinicline in more than 1,600 subjects who smoke cigarettes and have the desire to quit. The ORCA-OL clinical trial continues to evaluate longer-term safety exposure of the novel 3 mg cytisinicline three times a day dosing regimen in individuals who want to end their nicotine dependence.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img9551541_0.jpg" alt="img9551541_0.jpg" style="width:116px;height:130px;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">About ORCA-OL Trial</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">ORCA-OL is an open-label trial designed to evaluate the long-term exposure of 3 mg cytisinicline treatment dosed three times daily in adults 18 years of age or older who want to quit smoking or vaping and is being conducted at 29 clinical sites across the United States. The trial results are expected to meet the FDA's requirement for safety data from at least 300 participants treated with cytisinicline over a cumulative six-month period for the NDA submission. Additionally, data on at least 100 subjects treated for a cumulative one-year period will be provided prior to potential product approval.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:-3;min-height:1in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">About Achieve Life Sciences, Inc.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">Achieve Life Sciences is a late-stage specialty pharmaceutical company committed to addressing the global smoking health and nicotine dependence epidemic through the development and commercialization of cytisinicline. The company has successfully completed two Phase 3 studies with cytisinicline for smoking cessation and one Phase 2 study with cytisinicline in vaping cessation. The company has fully enrolled its ongoing open-label safety study with cytisinicline and plans to submit its new drug application for smoking cessation in Q2 2025.  Achieve has also conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">About Cytisinicline</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">There are approximately 29 million adults who smoke combustible cigarettes.</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">1</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;"> Tobacco use is currently the leading cause of preventable death that is responsible for more than eight million deaths worldwide and nearly half a million deaths in the United States annually.</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">2,3</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;"> More than 87% of lung cancer deaths, 61% of all pulmonary disease deaths, and 32% of all deaths from coronary heart disease are attributable to smoking and exposure to secondhand smoke.</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">3</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">In addition, there are over 11 million adults in the United States who use e-cigarettes, also known as vaping.</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">4</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;"> In 2024, approximately 1.6 million middle and high school students in the United States reported using e-cigarettes.</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">5</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;"> There are no FDA-approved treatments indicated specifically as an aid to nicotine e-cigarette cessation. Cytisinicline has been granted Breakthrough Therapy designation to address this critical need.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">Cytisinicline is a plant-based alkaloid with a high binding affinity to the nicotinic acetylcholine receptor. It is believed to aid in treating nicotine addiction for smoking and e-cigarette cessation by interacting with nicotine receptors in the brain, reducing the severity of nicotine craving symptoms, and reducing the reward and satisfaction associated with nicotine products. Cytisinicline is an investigational product candidate being developed for the treatment of nicotine addiction and has not been approved by the Food and Drug Administration for any indication in the United States.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">Forward Looking Statements</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">This press release contains forward-looking statements within the meaning of the &#x201c;safe harbor&#x201d; provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding the timing and nature of cytisinicline clinical development and regulatory review and approval, data results and commercialization activities, the potential market size for cytisinicline, the potential benefits, efficacy, safety and tolerability of cytisinicline, the development and effectiveness of new treatments, and the successful commercialization of cytisinicline. All statements other than statements of</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:-3;min-height:1in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">historical fact are statements that could be deemed forward-looking statements. Achieve may not actually achieve its plans or product development goals in a timely manner, if at all, or otherwise carry out its intentions or meet its expectations or projections disclosed in these forward-looking statements. These statements are based on management&#x2019;s current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements, including, among others, the risk that cytisinicline may not demonstrate the hypothesized or expected benefits; the risk that Achieve may not be able to obtain additional financing to fund the development and commercialization of cytisinicline; the risk that cytisinicline will not receive regulatory approval or be successfully commercialized; the risk that new developments in the smoking and vaping cessation landscapes require changes in business strategy or clinical development plans; the risk that Achieve&#x2019;s intellectual property may not be adequately protected; general business and economic conditions; risks related to the impact on our business of macroeconomic and geopolitical conditions, including inflation, volatile interest rates, volatility in the debt and equity markets, actual or perceived instability in the global banking system, global health crises and pandemics and geopolitical conflict and the other factors described in the risk factors set forth in Achieve&#x2019;s filings with the Securities and Exchange Commission from time to time, including Achieve&#x2019;s Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q. Achieve undertakes no obligation to update the forward-looking statements contained herein or to reflect events or circumstances occurring after the date hereof, other than as may be required by applicable.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">Achieve Contact</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">Nicole Jones</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;"><br></font><font><font style="white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">ir@achievelifesciences.com</font></font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">425-686-1510</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">References</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">1</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">VanFrank B, Malarcher A, Cornelius ME, Schecter A, Jamal A, Tynan M. Adult Smoking Cessation &#x2014; United States, 2022. MMWR Morb Mortal Wkly Rep 2024;73:633&#x2013;641.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">2</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">World Health Organization. WHO Report on the Global Tobacco Epidemic, 2019. Geneva: World Health Organization, 2017.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">3</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">U.S. Department of Health and Human Services. The Health Consequences of Smoking &#x2013; 50 Years of Progress. A Report of the Surgeon General, 2014.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">4</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">Cornelius ME, Loretan CG, Jamal A, et al. Tobacco Product Use Among Adults &#x2013; United States, 2021. MMWR Morb Mortal Wkly Rep 2023;72:475&#x2013;483.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">5</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;">Jamal A, Park-Lee E, Birdsey J, et al. Tobacco Product Use Among Middle and High School Students &#x2014; National Youth Tobacco Survey, United States, 2024. MMWR Morb Mortal Wkly Rep 2024;73:917&#x2013;924</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img9551541_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img9551541_0.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "" '0# 2(  A$! Q$!_\0
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M;-,EQM7!XF%GR5.1J5'$T)-+VF&Q="5/$X:JE:K0JTYKXK!1117IGSH4444
M%%%% !1110 4444 %?DO_P %8_\ @HY:?L&?"KP[;^#O[,UCXX?$35$C\'>'
MKX">VL/#VDW-O+XC\2:Q KK)'8K&\>DV&06N=0O08E9+2Y:/](OB[\4_!WP2
M^&?C?XL>/]5@T;P?X!\.:GXEUV_G=4"6>FVSS>1 &(\Z\O)1'9V-L@:6ZO)X
M+>)&DD53_FY?MK_M9^-?VS/VA/&_QJ\7RRPVFJ7LFF^#- ,LAM_#'@O3Y9(M
M!TB"-GD2.46N+K4&CP)]1N+F8YW#'ZEX6<$QXJSEXK,*7-DF5.-3%*5U#&8E
M^]0P2::;BW^^Q%G=4HJ#M[:$CX?CCB1Y%EZH86IRYGCDXX=K66'I1:57$-=&
MK\E*^]1N2NJ<D?W":^_PY_X*E?L1>&/BI\-IK0>)[S19-<\-I<M$+[POX]TF
M)K;Q'X+UDIYCVHFN[>YTV3)*/')8:G%O@>-F_FZU33[[1=0OM*U>TGT[4M,N
M[BQU"RNXVBN;2\M96AN+>>-AN26*5&1QSR#@D8-8/_!#O]ORY_9G^/EI\"_'
MFJ-'\&_CMK.GZ,KW4LC6WA/XB7;+8^']9C!<)!::W,]OH>ILL9^::RN7*I [
MC]GO^"K?[*P\*ZY;?M$^"M/9-!\1W<.F_$*SMHQY6EZ_*%CT[7RD: 1VVL?\
M>EY(Q(CU%(&)'VL ?R_]*WP<J</9I6S_ "RE*I2P]/VTII7EBLE<^6E5FTO?
MQ.5U)2P^)EK*6&<:TK4Z<4?Z _0+^D#"I*/AOQ!BU'"YQB)2R656?+# <1\B
M>(P$')M4\+GM.,:^#@O<AF$)48*5;%S/SK_9E_:%UW]G+XN>'?B'I'VBXTN"
M=-/\5Z1$Y"ZUX;NI$&H6JQLRQFZBC'VFQ:3A+J.,,RHS$_V!>#/%^@>/O"VA
M>,O"VHP:MX>\1Z;:ZKI6H6[9CGM+N-9$R.J2IGRYHFP\4JO&X#(:_AK+@9P>
M>?S_ *<]3G_Z_P"V?_!*']K)M'UJ3]FWQOJ2C2]:DN=1^&U[=R$+9ZN!YM_X
M7$DC[$BU%!)>Z8F.;N.XMP2UQ M?BO@IQQ_9.9OAC,:W+EV;54\!.I+W<+F<
MK0C33;M&GCDHTVMEB(TFDO:5)']!_3#\&GQ3P^O$G(<(I9]PQA7#/:-"%ZN9
M<.TVYO$R44_:8C)I2G6YK)RP%3$*4I?5Z,5_0/1117]<'^684444 %%%% !1
M110 4'@$^E%?EY_P5B_;RT[]A7]FG5O$&CWEF_Q?^(JW_A'X3Z1,5>5=7EM#
M_:'B>2W!#M8^&+69+QY&'E-?/86S[C<!3W99EV+S?'X3+,!2=7%XVO"A1AK;
MFD]9R:3M3IQ4JE23LHTXRDW9'+C<9A\OPE?&XJ:IT,/3E4J2>]EM&*ZSG*T(
M1WE*22W/P6_X.!/^"A"?$/QL/V+_ (7:Z9?!_P /=2AO_C%?Z=<G[+K?CBT8
MO9>$97B<+<0>%&V7.HPMNB36WCB<?:-/(C_F3W_[?_CW_P!>H]:U_5/$6L:M
MX@UR_N-4UK7=2OM8U?4[V62XO-1U/4KF6\O[Z[GD+237%U=32SS2NQ9Y'9B2
M37T7^QW^S%XV_;%_:"\!_ GP/%,ESXGU!9O$&LQ0M+#X8\)6+QR:_P"(;HD-
M&D5A:-MA$GRRWDUK  S2A3_;V0Y9E?!/#=+">TC2PN78:>)Q^,FE'VU91]IB
M\54ZWDTU".KC3C3I1;Y5?^9LUQN-XFSF>(<'4K8NM&CA,/%J7LZ;DH4*,-7I
M%-.<M%*4I5';F=OW _X("_\ !/QOB]\2?^&OOB;HHG^'7PKU=[;X966HVXDM
M/$WQ$M 1)K20SJ8[JR\(&19()@KQ)KQ@:-O/L&\O^R#Q]X&\/?$CP;XB\#>*
M;&+4= \2Z5=:5J-K,BNK0W4;()8]X(2>!RL\$@PT<T:.I!4&N7^!GP8\#?L]
M?"7P'\&OAOI46C^#O 'A^RT'2;2,#S)?(4O>:A>2  W&H:G>R7&H7]R^9+B[
MN9I7)+<>LU_'?'/$E3C3.<;C<5#FP,X3P>"P=5<T*67>]%4JD'>+G74I5,1N
MI3J2BFXI']%<)96^%,%@88*K*AF&'JTL;4QE"3IU5F$'"I&M2J1:E%T*D(JA
M)-.*IQDK2;9_%C^TO\#/$7[.?Q>\4?#/Q!%*T&GW/VWP[J91A!KGAN^+3:3J
M=O(1M<F$_9[Q 2;>^@N+=\-'D^(:3K6IZ!JNFZYH][/IVJZ1>VVHZ=>VLC0W
M%K>V<J3V\\,B,KJ\<J*P(/48Z&OZG?\ @I%^RDO[0GPEF\4^%M/\[XG?#:SO
M-6T+R$!N=<T94,^K^'<!=\LLT<(NM-0L<7D7EH/W[9_E$D8J65@R,K%7#@JR
MLIPRLIY# @@@C((((S7^<WB/PC6X)XCJ4*"J++<9*6-R:NFTXT>=.6'=1:JM
M@:C5-M/G</8UG9U5;_<CZ/\ XKX3Q@\/Z&*QSHSXBRJG3R;BS!2C!QJXET7&
MGCU1=T\)G%",JRBX^SC76,PL5)4+O^Q3]B#]IS2_VGO@QI7B1YH8O''ASRO#
MWC[2MRK-;ZW:V\3+J<46=QT[6H'6\M)@-@D-S:D^;;2J/L>OXW/V*/VH=3_9
M@^,VD>)Y)IY?!&OR6^A>/M,5F*3:)/.H&IQ1 X:]T:1OML#;2SQ+/!@^;Q_8
MAHNLZ;XATG3-=T:\@U#2-9T^SU33+^UD66VO=/U"WCNK.ZMY%^62&XMY8Y8W
M'!5@>]?U%X5\;QXPR"$<543SG*E3PN91;2E67+;#8U*]VL3&,E4:M;$0JJRC
M*%_\V_I*>#M3PHXYJRR[#SCPCQ++$9EP[42;IX1\\98[)9SM93RZK5A]7C)N
M4L!6PLG*=156M.BBBOT\_G0**** "BBCI0!S'C7QEX;^'GA'Q+XZ\8:K::'X
M6\(Z+J/B#Q!K%]*L-IIVDZ7;27=[=3R-P%BAB8@<L[;44%F /^;'_P %*OVX
M/$'[=G[3?B?XH7%Q>0^ -!\_PC\)O#]P[K%HW@FQO9Y8+EK9BJQZCKUS))J^
MI2%!,[S06\A"6D*1_O!_P<4_\%%6M;=/V$_A1K2B6[&G:Y\>]3T^Y(E2T4I?
MZ#\/I)(6(6.[<VVM:] ?G>*'3K27$4L\<O\ (/Y\G]U/S:OZ8\'^$?[/P;XF
MQ\%'&8^FX9;":M*A@)6<L19ZQJ8MKW7NL,E9M5I(_%O$+B!XO$+)<)4OA\+-
M2QDHO2KBDURTKJ]X8=23DMO;-IJ])&U%NFDCAA1Y9I76.**-2\DDCL$2-$7+
M.[LP5$4%F8@ $U_?S_P0Y_X)[C]D/]GT_%7XA:+';?'3X[:=I6LZT+J-&O\
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M/^"CG[$G_!2^Y\*ZSXI^"W@1X_ GQ2N=*M9;IO#4=[%KVASS3%%D2U>Z\/\
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M0I1;P$6H13C2Q]2I33]VZA.3C*4=]7%/1W2U1^@_[,WPM_9H^'O@6?6_V7O
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MX/?%C2?CM\&?$-CXHSI#Z;!-XP^"FG:1:C4-+>_\4:.+>RO/#]S=3'0X=/\
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MZ_\ CI?^G8#K_P"Y8+_KU7_],3'?\/6?^"HOV@W?_#R3]OG[48A ;G_AL/\
M:'^T&$,7$)F_X6+YGE!R6$>[8&);&235&^_X*C?\%,]4DBFU+_@HK^W7J,L)
M!AEOOVN?C_=R0D'(,3W'Q!D:,@\@H1@\T448K_=J_P#U]7_I<2<O_P!]H_\
M8,__ $VR6Z_X*F_\%.KY(H[W_@HU^WA>1P?ZF.Z_:]_:"N$AX"_NDE^(3K'\
MH ^0#@ =!31_P5*_X*;BS?3A_P %&/V[AI\F?,L1^UW^T#]CDW$$[[7_ (6%
MY#9(!.Y#D@$\BBBE+^-B/^P67_I,#2G_ +E@_P#L/A_Z<F26?_!5#_@I[I\"
MVMA_P4=_;RL;9"2EO9_M?_M!VT"%N25AA^(:1J2>I"C/>BBBM\/_  :7^"'Y
14SAQG^]XC_K_ %/_ $N)_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>achv-20250210.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-02-10T13:39:33.7211+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://ir.achievelifesciences.com/20250210" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:achv="http://ir.achievelifesciences.com/20250210" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" namespace="http://fasb.org/us-gaap/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" namespace="http://www.xbrl.org/dtr/type/2022-03-31"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://www.esma.europa.eu/xbrl/esef/arcrole/wider-narrower" xlink:href="http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd#wider-narrower" xlink:type="simple"/>
        <link:roleRef roleURI="http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:href="achv-20250210.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="dei_AddressTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherAddressMember" xlink:label="dei_OtherAddressMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Addresses, Address Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentInformationTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Information [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Country</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Country</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Address Line 1</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AddressTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Address Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Address Line 2</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_OtherAddressMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Principal Address</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_OtherAddressMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Address [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Act File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentInformationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Information [Line Items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AddressTypeDomain" xlink:to="dei_AddressTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherAddressMember" xlink:to="dei_OtherAddressMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="dei_AddressTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherAddressMember" xlink:label="dei_OtherAddressMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_EntityAddressesAddressTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_AddressTypeDomain" xlink:to="dei_OtherAddressMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCountry" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentInformationTable" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="dei_AddressTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="dei_AddressTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherAddressMember" xlink:label="dei_OtherAddressMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_EntityAddressesAddressTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_AddressTypeDomain" xlink:to="dei_OtherAddressMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCountry" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" priority="2" use="optional"/>
        </link:definitionLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45966815695184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 10, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 10,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ACHIEVE LIFE SCIENCES, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000949858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">033-80623<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">95-4343413<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">22722 29th Drive SE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address Address Line 2</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Bothell<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">WA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">98021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">604<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">210-2217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ACHV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_OtherAddressMember', window );">Principal Address</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">1040 West Georgia<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address Address Line 2</a></td>
<td class="text">Suite 1030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Vancouver<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">BC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">V6E 4H1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_OtherAddressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_OtherAddressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>7
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M4$L! A0#%     @ 2(%*6L]VA(+N    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ 2(%*6IE<G",0!@  G"<
M !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    " !(@4I:5&'>0@H%  !,%@  &               @($-"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ 2(%*6I^@&_"Q @  X@P
M  T              ( !30T  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !(
M@4I:EXJ[',     3 @  "P              @ $I$   7W)E;',O+G)E;'-0
M2P$"% ,4    " !(@4I:'#AEZC\!   \ @  #P              @ $2$0
M>&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ 2(%*6B0>FZ*M    ^ $  !H
M             ( !?A(  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!
M A0#%     @ 2(%*6F60>9(9 0  SP,  !,              ( !8Q,  %M#
G;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  K10

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="achv-20250210.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="achv-20250210.htm">achv-20250210.htm</File>
    <File>achv-20250210.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "achv-20250210.htm": {
   "nsprefix": "achv",
   "nsuri": "http://ir.achievelifesciences.com/20250210",
   "dts": {
    "inline": {
     "local": [
      "achv-20250210.htm"
     ]
    },
    "schema": {
     "local": [
      "achv-20250210.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 30,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 29
   },
   "report": {
    "R1": {
     "role": "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "achv-20250210.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "achv-20250210.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address Address Line 1",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address Address Line 2",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Act File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principal Address",
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://ir.achievelifesciences.com/20250210/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0000950170-25-017068-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-25-017068-xbrl.zip
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M>R3?@K'CF$<1'Z,S$=,X$#1"G<FH1S#-H(9.HPA=RM<R=,DSG@XYJQ6==G.
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M3;AGS:TTQW::S=J7'=3J]:-D+$_)+&"TM\)'\Z8E.D]J"]EI,[8<+$T.]>'
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M.M3"GFV&U L)]^G:/D9INHPUW5=B<),&L'1F@)HZ>1)\.T)@#Z AC08<_3=
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M2&3C+*<QHRG+BG,0;%E V#BDTX#PK.RO+18:V\@XVT GKW]D2J_I5C]'+!F
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MI.XG;/SQ;R?U;MZ+/OX_4$L#!!0    ( $B!2EHZ>>EK;0T  +O(   1
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MSZ+K):'O,S^F\HK>X)5YD8J*MN7:*W?S>FM8I=7X3=%SV?X4TS^BV.7K8;J
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M)IVK4)GLGI^-Q8A^E]"E*? "<C$BWB74^L1X@;LFF*S#,BA+E\\OA87X:Y?
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M,C$P+GAS9%!+ 0(4 Q0    ( $B!2EH/HX<O%Q,  !)O   /
M  "  =\D  !A8VAV+65X.3E?,2YH=&U02P4&      ,  P"[    (S@

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>achv-20250210_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="achv-20250210.xsd" xlink:type="simple"/>
    <context id="C_a3d0af1b-4e13-4822-9148-507ec4d52c9f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000949858</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:OtherAddressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-10</startDate>
            <endDate>2025-02-10</endDate>
        </period>
    </context>
    <context id="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000949858</identifier>
        </entity>
        <period>
            <startDate>2025-02-10</startDate>
            <endDate>2025-02-10</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd"
      id="F_62a9e576-8a48-4881-b996-0d85c925e306">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd"
      id="F_7f90f156-3ad3-4352-b8f4-80350751b49f">0000949858</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd"
      id="F_d6d3906d-ddcd-4119-ac46-cb3ccdb112c5">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd"
      id="F_8ffa17e2-8832-4ad2-a8ce-32f94653a8ff">2025-02-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd"
      id="F_8e937ade-1da2-4a51-afe2-51e4e1d9e5fd">ACHIEVE LIFE SCIENCES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd"
      id="F_98cd1da7-3a16-4926-83e9-f7d933597da8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd"
      id="F_bdd60083-c35c-4064-a551-e2c99d82daea">033-80623</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd"
      id="F_0dd18008-62be-402c-97df-560911ba2539">95-4343413</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd"
      id="F_2bd0c80e-9bdc-4f30-9bb9-644aee26afc8">22722 29th Drive SE</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd"
      id="F_a7075460-fa16-43eb-bd28-6c0b00f2af7c">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd"
      id="F_469957d2-a73f-4b6a-9961-36fe379d6343">Bothell</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd"
      id="F_d67fe97b-c806-4d7d-a16a-df7e0e104b52">WA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd"
      id="F_40299683-fd51-40b6-bcbf-8f96a1875f5c">98021</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressAddressLine1
      contextRef="C_a3d0af1b-4e13-4822-9148-507ec4d52c9f"
      id="F_b95ef069-f7ed-4f09-a321-bca531ee3c66">1040 West Georgia</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_a3d0af1b-4e13-4822-9148-507ec4d52c9f"
      id="F_71bc7558-c268-48c1-90e5-d063bbd68f6f">Suite 1030</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_a3d0af1b-4e13-4822-9148-507ec4d52c9f"
      id="F_35fc844c-e145-477a-9961-0165f3ba0cca">Vancouver</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_a3d0af1b-4e13-4822-9148-507ec4d52c9f"
      id="F_8c782576-69da-41f1-968f-bc3f74d1ca70">BC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressCountry
      contextRef="C_a3d0af1b-4e13-4822-9148-507ec4d52c9f"
      id="F_cc363098-3980-4b30-b87b-cbdd774c229f">CA</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode
      contextRef="C_a3d0af1b-4e13-4822-9148-507ec4d52c9f"
      id="F_5c01132e-02e2-45bb-81de-db9ac4cbb842">V6E 4H1</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd"
      id="F_d048b0b7-35b0-4fa1-b156-58021a94ddd1">604</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd"
      id="F_2bb12bd3-6884-4cd9-b7d9-e99750b6571d">210-2217</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd"
      id="F_a94867dd-f096-4925-866f-fe3f7be0db2a">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd"
      id="F_6658b33e-fa3b-4582-b72b-d014b3c6d224">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd"
      id="F_e2517eda-df90-4de2-b707-9ca9ebe4f82f">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd"
      id="F_3411db8f-c792-40ac-856c-24408f776486">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd"
      id="F_c397f2a0-4fce-4a3b-87a5-964fa9f0eba6">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd"
      id="F_7a5dfa64-37ec-4a19-8b75-003b9f9fe625">ACHV</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd"
      id="F_abdbf461-5fd3-496f-ac04-97d2b9c715cc">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_641e6f98-09a1-46fc-84ee-732cd3c5d5bd"
      id="F_e4d0f7a6-09f5-44eb-b1d2-0429952d054c">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
